Plant stanols and asthma symptoms prevention
Part of Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether eating plant stanols (a natural substance found in some foods) can help prevent asthma symptoms in people with stable allergic asthma. You would need to take a daily chew and avoid certain cholesterol-lowering products during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with allergic asthma that is well-controlled and stable for the past 3 months.
- You have been using asthma medication for at least 1 year.
- You are between 18 and 70 years old.
- Your BMI is between 20 and 35.
- You agree not to eat any foods with added plant sterols or stanols (like certain margarines or yogurt drinks) for 1 month before and during the study.
- You agree to keep your fish oil supplement intake the same during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study looks at how asthma-related inflammation works and whether a diet-related approach could help. It may be most relevant if you have confirmed asthma and can follow the study’s diet requirements.
This study tests whether taking ginger can help people whose asthma is not well controlled with their current inhalers. If you join, you will take ginger supplements and monitor your asthma symptoms and breathing tests.
This trial tests if a daily supplement called astaxanthin can help people with mild-to-moderate asthma, especially in areas with more air pollution. You would take capsules and track your breathing at home.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.
This trial tests a new drug called ADO-5030 in people with mild to moderate asthma to see how it affects their airway sensitivity. Participants will have breathing tests using AMP (a substance that can trigger asthma-like symptoms) to measure the drug's effects.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.